Skip to main content

Over $7 million in funding guarantees research towards diagnosis of rare diseases

Researchers at London Health Sciences Centre are expanding an artificial intelligence driven diagnosing tool for rare genetic diseases called EpiSign™. (Source: London Health Sciences Centre) Researchers at London Health Sciences Centre are expanding an artificial intelligence driven diagnosing tool for rare genetic diseases called EpiSign™. (Source: London Health Sciences Centre)
Share

Researchers at London Health Sciences Centre are expanding an artificial intelligence driven diagnosing tool for rare genetic diseases called EpiSign™.

"We have developed the largest database in the world of patients with various different genetic diseases. We use the database to develop specialized software," says Dr. Bekim Sadikovic, LHSC Genomics Research Chair.

Dr. Bekim Sadikovic, London Health Sciences Centre Genomics Research Chair (Source: London Health Sciences Centre) Researchers say it takes up to seven years to properly diagnose some rare genetic diseases, but with EpiSign™, that timeline could be drastically reduced with a single blood test.

"To receive specialized care, you need a specific genetic diagnosis. Without one, you can't access therapy and, unlike other types of diseases, genetic diseases don't only affect the patient, they affect whole family because they can be inherited."

The technology has been 10 years in the making, but with a $7.5 million dollar grant, it will be expanded to labs in 15 countries around the world.

70 per cent of rare genetic diseases go undiagnosed. 

CTVNews.ca Top Stories

Jasper mayor says alert system to be reviewed after message 'glitch'

More than 25,000 people have been displaced from Jasper National Park since wildfires started to threaten the picturesque corner of Alberta Rockies on Monday, but the mayor of its namesake municipality says not everyone received an evacuation alert when it was sent out.

Stay Connected